Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the

Jing Chang1, Yanming Yu2, Zhan Fang1

  • 1Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China.

Abstract

Insights

Long non-coding RNA CDKN2B-AS1 promotes diabetic nephropathy by upregulating WNT2B via the miR-15b-5p pathway. This study reveals a novel mechanism in diabetic nephropathy development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Nephrology

Background:

  • Diabetic nephropathy (DN) is a significant complication of diabetes.
  • Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) is implicated in DN progression.
  • The precise regulatory mechanisms of CDKN2B-AS1 in DN remain largely unknown.

Purpose of the Study:

  • To elucidate the role and regulatory mechanisms of CDKN2B-AS1 in high glucose-induced human mesangial cell (HMC) dysfunction.
  • To investigate the interplay between CDKN2B-AS1, microRNA (miR)-15b-5p, and wingless-Type family member 2B (WNT2B) in the context of DN.

Main Methods:

  • Established a DN model using high glucose (HG)-induced HMCs.
  • Quantified expression levels of CDKN2B-AS1, miR-15b-5p, and WNT2B mRNA using qRT-PCR.
  • Assessed HMC viability, cell cycle, ECM accumulation, and inflammation via CCK-8, flow cytometry, western blotting, and ELISA.
  • Utilized dual-luciferase reporter assays to confirm interactions between CDKN2B-AS1, miR-15b-5p, and WNT2B.

Main Results:

  • CDKN2B-AS1 and WNT2B were upregulated, while miR-15b-5p was downregulated in DN patients' serum and HG-treated HMCs.
  • Inhibition of CDKN2B-AS1 ameliorated HG-induced HMC viability, cell cycle progression, ECM accumulation, and inflammation.
  • CDKN2B-AS1 directly targeted miR-15b-5p, influencing WNT2B expression.
  • MiR-15b-5p and WNT2B manipulations reversed the effects of CDKN2B-AS1 knockdown or overexpression, confirming the regulatory axis.

Conclusions:

  • CDKN2B-AS1 exacerbates HG-induced HMC dysfunction through the miR-15b-5p/WNT2B pathway.
  • This study provides a novel molecular mechanism underlying diabetic nephropathy development.
  • Targeting the CDKN2B-AS1/miR-15b-5p/WNT2B axis may offer therapeutic strategies for DN.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
15.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.5K